Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
KEGG_2021_Human,Ribosome,14/158,2.920989730291192e-05,0.0059422933448708,0,0,4.033577206757078,42.11459154461284,RPL5;RPL3;RPL31;RPS8;RPL12;RPS4X;RPS14;RPL37A;RPL38;FAU;RPS27A;RPL28;RPS21;RPS13
KEGG_2021_Human,Coronavirus disease,17/232,4.972630414117906e-05,0.0059422933448708,0,0,3.2895749799518845,32.59632119269923,RPL5;NRP1;RPL3;RPL31;RPS8;RPL12;MX2;RPS4X;RPS14;OAS3;RPL37A;RPL38;FAU;RPS27A;RPL28;RPS21;RPS13
KEGG_2021_Human,AMPK signaling pathway,11/120,0.0001526884816893066,0.0121641823745814,0,0,4.167675190318173,36.62182359057067,RAB10;TBC1D1;PRKAB2;LEPR;CD36;ADIPOR2;PPARGC1A;SIRT1;PFKM;PFKP;IGF1R
KEGG_2021_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,4/26,0.0032452090947424,0.1939012434108594,0,0,7.431675242995998,42.58777603376035,PIGU;PGAP1;PIGQ;PIGL
KEGG_2021_Human,Cysteine and methionine metabolism,5/50,0.006857817428032,0.3278036730599332,0,0,4.545751633986928,22.648598599483574,IL4I1;AHCYL2;GCLC;MDH2;APIP
KEGG_2021_Human,FoxO signaling pathway,8/131,0.0139789085319207,0.5568265231881765,0,0,2.6670791866481034,11.38897652851234,GABARAPL1;MAP2K1;PRKAB2;CCNG2;TNFSF10;SIRT1;IGF1R;TGFBR2
KEGG_2021_Human,Adipocytokine signaling pathway,5/69,0.0251727112768482,0.8205524681859857,0,0,3.1931131827731094,11.757025997633386,PRKAB2;LEPR;CD36;ADIPOR2;PPARGC1A
KEGG_2021_Human,Sphingolipid metabolism,4/49,0.0298909392285087,0.8205524681859857,0,0,3.628977405078034,12.73843605308311,ACER2;ARSA;GLB1;DEGS2
KEGG_2021_Human,Pentose phosphate pathway,3/30,0.0347126445086312,0.8205524681859857,0,0,4.530915853091585,15.226828085796054,GLYCTK;PFKM;PFKP
KEGG_2021_Human,Circadian rhythm,3/31,0.0377660131801081,0.8205524681859857,0,0,4.368873281530186,14.313939203018723,PRKAB2;PER3;RORA
KEGG_2021_Human,Galactose metabolism,3/31,0.0377660131801081,0.8205524681859857,0,0,4.368873281530186,14.313939203018723,GLB1;PFKM;PFKP
KEGG_2021_Human,RNA degradation,5/79,0.0416741130145064,0.8300094175389193,0,0,2.7601919146036797,8.771545250395636,BTG2;PABPC1L;PFKM;PFKP;DCP1B
KEGG_2021_Human,Nicotinate and nicotinamide metabolism,3/35,0.051289065209802,0.942929737318668,0,0,3.821979602510461,11.35234079592248,NMNAT2;SIRT1;NUDT12
KEGG_2021_Human,Long-term depression,4/60,0.0561688570110189,0.9456163818249332,0,0,2.9144953578915844,8.391977011485695,MAP2K1;PLA2G4C;CACNA1A;IGF1R
KEGG_2021_Human,Aminoacyl-tRNA biosynthesis,4/66,0.0743965440376396,0.9456163818249332,0,0,2.6316358963954825,6.837900050446174,NARS1;QARS1;HARS2;WARS1
KEGG_2021_Human,Ferroptosis,3/41,0.075301918625336,0.9456163818249332,0,0,3.217518167804448,8.321305282807279,GCLC;FTH1;SAT1
KEGG_2021_Human,Fc epsilon RI signaling pathway,4/68,0.0810609047946513,0.9456163818249332,0,0,2.549135220125786,6.404841157749831,VAV3;MAP2K1;PLA2G4C;BTK
KEGG_2021_Human,Mitophagy,4/68,0.0810609047946513,0.9456163818249332,0,0,2.549135220125786,6.404841157749831,GABARAPL1;UBC;TOMM7;RPS27A
KEGG_2021_Human,Adherens junction,4/71,0.0915886768601388,0.9456163818249332,0,0,2.434619356049939,5.819830069638772,FER;YES1;IGF1R;TGFBR2
KEGG_2021_Human,Longevity regulating pathway,5/102,0.0996686585796354,0.9456163818249332,0,0,2.103222732391926,4.849829729833428,PRKAB2;ADIPOR2;PPARGC1A;SIRT1;IGF1R
KEGG_2021_Human,Protein digestion and absorption,5/103,0.1028098674951342,0.9456163818249332,0,0,2.081654090207512,4.735500648695347,COL18A1;CPA1;COL16A1;COL5A1;COL5A3
KEGG_2021_Human,Pathogenic Escherichia coli infection,8/197,0.1038416173693624,0.9456163818249332,0,0,1.7298119623701018,3.917831135206904,TUBB8;TUBA1C;WIPF3;TNFSF10;ARHGEF1;GAPDH;NAIP;MYO1G
KEGG_2021_Human,Protein export,2/23,0.1048736368151408,0.9456163818249332,0,0,3.876727308877622,8.742016640792599,IMMP2L;SRP14
KEGG_2021_Human,Systemic lupus erythematosus,6/135,0.1075972237383364,0.9456163818249332,0,0,1.8986536107711136,4.232783236349058,H2AC8;H2BC7;SSB;H2AC6;H2BC4;H4C3
KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",5/106,0.1125238514678953,0.9456163818249332,0,0,2.0195107746068723,4.41180317792358,EGR1;MAP2K1;MMP17;PDE4A;ARHGEF1
KEGG_2021_Human,Apelin signaling pathway,6/137,0.1132905168762603,0.9456163818249332,0,0,1.8694736842105264,4.071339441171684,EGR1;GABARAPL1;MAP2K1;PRKAB2;PPARGC1A;MYLK
KEGG_2021_Human,Autophagy,6/137,0.1132905168762603,0.9456163818249332,0,0,1.8694736842105264,4.071339441171684,GABARAPL1;MAP2K1;RRAGD;IGF1R;CTSB;RAB33B
KEGG_2021_Human,Glucagon signaling pathway,5/107,0.1158568769348902,0.9456163818249332,0,0,1.9996086669962103,4.309955859342207,PRKAB2;PPARGC1A;SIRT1;PFKM;PFKP
KEGG_2021_Human,Antigen processing and presentation,4/78,0.1185010949799824,0.9456163818249332,0,0,2.203524278995977,4.699749470666039,NFYC;HLA-B;B2M;CTSB
KEGG_2021_Human,Cholesterol metabolism,3/50,0.1186966169654727,0.9456163818249332,0,0,2.6001958515089467,5.541497039756371,OSBPL5;VAPB;CD36
KEGG_2021_Human,HIF-1 signaling pathway,5/109,0.1226621074939701,0.9456852803567376,0,0,1.9609526502908856,4.114709689658485,MAP2K1;GAPDH;PFKM;PFKP;IGF1R
KEGG_2021_Human,"Phenylalanine, tyrosine and tryptophan biosynthesis",1/6,0.1359128224562163,0.9515627972731294,0,0,8.130833333333333,16.22704240839014,IL4I1
KEGG_2021_Human,Glyoxylate and dicarboxylate metabolism,2/30,0.1620109955929498,0.9515627972731294,0,0,2.9065016403221,5.29009768636911,MDH2;GLYCTK
KEGG_2021_Human,Notch signaling pathway,3/59,0.1691313040564996,0.9515627972731294,0,0,2.1812985654512853,3.876341877235512,MAML2;MFNG;RFNG
KEGG_2021_Human,Cellular senescence,6/156,0.1744213670731922,0.9515627972731294,0,0,1.6310736842105262,2.848313404159572,MAP2K1;HLA-B;HUS1;SIRT1;MCU;TGFBR2
KEGG_2021_Human,Platelet activation,5/124,0.1791196166960665,0.9515627972731294,0,0,1.7124496857566556,2.9449022018632736,RAP1A;PLA2G4C;BTK;ARHGEF1;MYLK
KEGG_2021_Human,Necroptosis,6/159,0.185126862134952,0.9515627972731294,0,0,1.598844169246646,2.69679276038226,H2AC8;H2AC6;FTH1;PLA2G4C;TNFSF10;STAT4
KEGG_2021_Human,Fructose and mannose metabolism,2/33,0.187928108768049,0.9515627972731294,0,0,2.6248232204188837,4.387905925639875,PFKM;PFKP
KEGG_2021_Human,Osteoclast differentiation,5/127,0.1914287098989097,0.9515627972731294,0,0,1.6700819672131149,2.7610459970661823,MAP2K1;CALCR;BTK;FOSL2;TGFBR2
KEGG_2021_Human,Lysosome,5/128,0.1955972644746573,0.9515627972731294,0,0,1.6564186650269863,2.7027742059127013,ARSA;GLB1;TPP1;ARSG;CTSB
KEGG_2021_Human,Fc gamma R-mediated phagocytosis,4/97,0.205326403343053,0.9515627972731294,0,0,1.7516286828520546,2.7730985769676897,VAV3;MAP2K1;GSN;PLA2G4C
KEGG_2021_Human,Glycolysis / Gluconeogenesis,3/67,0.2181475093675876,0.9515627972731294,0,0,1.9078517259414225,2.904864124121646,GAPDH;PFKM;PFKP
KEGG_2021_Human,"Alanine, aspartate and glutamate metabolism",2/37,0.2232457810046979,0.9515627972731294,0,0,2.324366239188786,3.485345238237741,IL4I1;NIT2
KEGG_2021_Human,Central carbon metabolism in cancer,3/70,0.2372323115598431,0.9515627972731294,0,0,1.822144507587585,2.621547364810404,MAP2K1;PFKM;PFKP
KEGG_2021_Human,Salmonella infection,8/249,0.2518186077780557,0.9515627972731294,0,0,1.3529251796162922,1.8657464104480368,TUBB8;TUBA1C;MAP2K1;DYNLT1;TNFSF10;FLNA;GAPDH;NAIP
KEGG_2021_Human,Endocytosis,8/252,0.2619363653759932,0.9515627972731294,0,0,1.3360829029910235,1.7898883844113591,RAB10;ACAP1;WIPF3;HLA-B;EPN1;SNX6;IGF1R;TGFBR2
KEGG_2021_Human,NOD-like receptor signaling pathway,6/181,0.2703364710692826,0.9515627972731294,0,0,1.3962586466165414,1.8264290502468992,GABARAPL1;OAS3;CARD16;NAIP;MCU;CTSB
KEGG_2021_Human,Human T-cell leukemia virus 1 infection,7/219,0.2757696919806737,0.9515627972731294,0,0,1.344926757423772,1.7325201384407205,EGR1;NRP1;ZFP36;MAP2K1;HLA-B;B2M;TGFBR2
KEGG_2021_Human,Serotonergic synapse,4/113,0.2888313909040086,0.9515627972731294,0,0,1.4932779412613235,1.854520068759987,MAP2K1;TRPC1;PLA2G4C;CACNA1A
KEGG_2021_Human,Alcoholism,6/186,0.2909616726363302,0.9515627972731294,0,0,1.3571228070175438,1.675454594209132,H2AC8;MAP2K1;H2BC7;H2AC6;H2BC4;H4C3
KEGG_2021_Human,Leukocyte transendothelial migration,4/114,0.2942267666448592,0.9515627972731294,0,0,1.4796264532113588,1.810181652056692,VAV3;ITK;RAP1A;MSN
KEGG_2021_Human,Glycosphingolipid biosynthesis,2/45,0.2948425583076755,0.9515627972731294,0,0,1.891149196484925,2.30968654677896,GLB1;B3GNT2
KEGG_2021_Human,Neutrophil extracellular trap formation,6/189,0.3034904373548917,0.9515627972731294,0,0,1.3346678170836928,1.5914648144931698,H2AC8;MAP2K1;H2BC7;H2AC6;H2BC4;H4C3
KEGG_2021_Human,B cell receptor signaling pathway,3/81,0.3090361787871316,0.9515627972731294,0,0,1.564290312198262,1.8369413041798013,VAV3;MAP2K1;BTK
KEGG_2021_Human,Other types of O-glycan biosynthesis,2/47,0.3126789011608712,0.9515627972731294,0,0,1.806912549292508,2.1006776629327475,MFNG;RFNG
KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,6/193,0.3203420281240239,0.9515627972731294,0,0,1.3058485786659162,1.4865336441274803,GABARAPL1;ZFP36;MAP2K1;UBC;HLA-B;RPS27A
KEGG_2021_Human,Ether lipid metabolism,2/49,0.330416074027025,0.9515627972731294,0,0,1.7298449784568917,1.9156348065283144,PLA2G4C;GDPD1
KEGG_2021_Human,Thyroid hormone signaling pathway,4/121,0.3322867925713665,0.9515627972731294,0,0,1.3906000824239817,1.532103166293811,MAP2K1;NCOA3;PFKM;PFKP
KEGG_2021_Human,Nitrogen metabolism,1/17,0.3390080063546135,0.9515627972731294,0,0,2.539453125,2.747006576017212,CA8
KEGG_2021_Human,Phenylalanine metabolism,1/17,0.3390080063546135,0.9515627972731294,0,0,2.539453125,2.747006576017212,IL4I1
KEGG_2021_Human,Ovarian steroidogenesis,2/51,0.348023262833934,0.9515627972731294,0,0,1.6590686378935708,1.7511236443800715,PLA2G4C;IGF1R
KEGG_2021_Human,Focal adhesion,6/201,0.354410177376586,0.9515627972731294,0,0,1.2517570850202429,1.2984480542212202,VAV3;MAP2K1;RAP1A;FLNA;MYLK;IGF1R
KEGG_2021_Human,Other glycan degradation,1/18,0.3549183614192739,0.9515627972731294,0,0,2.389950980392157,2.475672508431685,GLB1
KEGG_2021_Human,Gap junction,3/88,0.3552214202140713,0.9515627972731294,0,0,1.434949544671425,1.485192817842112,TUBB8;TUBA1C;MAP2K1
KEGG_2021_Human,Viral carcinogenesis,6/203,0.3629770774948911,0.9515627972731294,0,0,1.238920651883516,1.2555415084814037,H2BC7;GSN;H2BC4;HLA-B;SCRIB;H4C3
KEGG_2021_Human,Glycosaminoglycan biosynthesis,2/53,0.3654727941646771,0.9515627972731294,0,0,1.593843382864628,1.6043044737073675,B3GNT2;HS3ST5
KEGG_2021_Human,Hypertrophic cardiomyopathy,3/90,0.3683670481411056,0.9515627972731294,0,0,1.4018179194921367,1.3999611057820431,PRKAB2;TPM2;EMD
KEGG_2021_Human,Glycosaminoglycan degradation,1/19,0.370446523825291,0.9515627972731294,0,0,2.257060185185185,2.241364994516838,GLB1
KEGG_2021_Human,Proteoglycans in cancer,6/205,0.371555176262365,0.9515627972731294,0,0,1.226342237503306,1.2141498239483626,VAV3;MAP2K1;FLNA;MSN;ARHGEF1;IGF1R
KEGG_2021_Human,Tight junction,5/169,0.3839286010840149,0.9515627972731294,0,0,1.2396879483500718,1.1867516345336615,TUBA1C;PRKAB2;RAP1A;MSN;SCRIB
KEGG_2021_Human,One carbon pool by folate,1/20,0.3856016558621654,0.9515627972731294,0,0,2.138157894736842,2.037558468106244,MTHFD1
KEGG_2021_Human,Natural killer cell mediated cytotoxicity,4/131,0.3869495205426072,0.9515627972731294,0,0,1.280443718120141,1.2157314144525928,VAV3;MAP2K1;TNFSF10;HLA-B
KEGG_2021_Human,GnRH signaling pathway,3/93,0.3879915917510577,0.9515627972731294,0,0,1.354881450488145,1.282763292696253,EGR1;MAP2K1;PLA2G4C
KEGG_2021_Human,Hedgehog signaling pathway,2/56,0.3912980632056115,0.9515627972731294,0,0,1.5050645635196784,1.412180556652325,SPOPL;CSNK1G1
KEGG_2021_Human,Parkinson disease,7/249,0.3917716339596992,0.9515627972731294,0,0,1.1763695644593228,1.1023478922955303,TUBB8;TUBA1C;PSMB3;UBC;RPS27A;COX7C;MCU
KEGG_2021_Human,Vascular smooth muscle contraction,4/133,0.3978406457621748,0.9515627972731294,0,0,1.2604618659906066,1.161772417783651,MAP2K1;PLA2G4C;ARHGEF1;MYLK
KEGG_2021_Human,Influenza A,5/172,0.3982403421366397,0.9515627972731294,0,0,1.217229406732753,1.120702605053672,NXF1;MAP2K1;OAS3;MX2;TNFSF10
KEGG_2021_Human,Pantothenate and CoA biosynthesis,1/21,0.4003927004979194,0.9515627972731294,0,0,2.031145833333333,1.8591270004229512,PANK3
KEGG_2021_Human,MAPK signaling pathway,8/294,0.4119893394236517,0.9515627972731294,0,0,1.1373911500761396,1.0085904798416117,MAP2K1;RAP1A;PLA2G4C;FLNA;CACNA1A;DUSP6;IGF1R;TGFBR2
KEGG_2021_Human,Lipid and atherosclerosis,6/215,0.4144672095577044,0.9515627972731294,0,0,1.1670611936539914,1.0279024694362269,VAV3;RAP1A;POU2F1;TNFSF10;ARHGEF1;CD36
KEGG_2021_Human,VEGF signaling pathway,2/59,0.416641134405585,0.9515627972731294,0,0,1.4256308830531443,1.2481826307877275,MAP2K1;PLA2G4C
KEGG_2021_Human,Yersinia infection,4/137,0.4195185006193607,0.9515627972731294,0,0,1.2223010356078876,1.0617489251700825,VAV3;MAP2K1;WIPF3;ARHGEF1
KEGG_2021_Human,Glycerophospholipid metabolism,3/98,0.4203460864447358,0.9515627972731294,0,0,1.2832415767452103,1.1121558210008573,GNPAT;PLA2G4C;ADPRM
KEGG_2021_Human,Mineral absorption,2/60,0.4249709398533189,0.9515627972731294,0,0,1.40097905118422,1.198866092760778,MT2A;FTH1
KEGG_2021_Human,Regulation of actin cytoskeleton,6/218,0.4272988639205201,0.9515627972731294,0,0,1.1503674280039722,0.9781247479317304,VAV3;MAP2K1;GSN;MSN;ARHGEF1;MYLK
KEGG_2021_Human,Progesterone-mediated oocyte maturation,3/100,0.4331315127346116,0.9515627972731294,0,0,1.2566535823663891,1.0514594853358952,MAP2K1;SPDYE3;IGF1R
KEGG_2021_Human,Glycerolipid metabolism,2/61,0.4332384378045897,0.9515627972731294,0,0,1.3771628746328863,1.1519513504005463,GLYCTK;MGLL
KEGG_2021_Human,Ubiquitin mediated proteolysis,4/140,0.4356573137194156,0.9515627972731294,0,0,1.195153533111358,0.9930522608062198,UBC;UBE2D1;UBE2E2;RPS27A
KEGG_2021_Human,Pancreatic secretion,3/102,0.4458122903624116,0.9515627972731294,0,0,1.2311398503867124,0.994585302136254,CPA1;RAP1A;TRPC1
KEGG_2021_Human,Apoptosis,4/142,0.4463469089518104,0.9515627972731294,0,0,1.1777109348889496,0.950010897195483,TUBA1C;MAP2K1;TNFSF10;CTSB
KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,4/143,0.4516684286702286,0.9515627972731294,0,0,1.1691778652549658,0.9292706734827124,MAP2K1;KLF4;ACVR2A;IGF1R
KEGG_2021_Human,Spinocerebellar ataxia,4/143,0.4516684286702286,0.9515627972731294,0,0,1.1691778652549658,0.9292706734827124,PSMB3;CACNA1A;RORA;MCU
KEGG_2021_Human,alpha-Linolenic acid metabolism,1/25,0.4560874828527986,0.9515627972731294,0,0,1.6922743055555556,1.3285548712835848,PLA2G4C
KEGG_2021_Human,GnRH secretion,2/64,0.4576494639352166,0.9515627972731294,0,0,1.3103239275372078,1.0242169916740125,MAP2K1;TRPC1
KEGG_2021_Human,T cell receptor signaling pathway,3/104,0.4583791526925774,0.9515627972731294,0,0,1.2066365632379137,0.9412472198240944,VAV3;ITK;MAP2K1
KEGG_2021_Human,Inflammatory bowel disease,2/65,0.465650706551688,0.9515627972731294,0,0,1.2894588593962288,0.9855585283388062,STAT4;RORA
KEGG_2021_Human,Acute myeloid leukemia,2/67,0.481441220372952,0.9515627972731294,0,0,1.2496547294042075,0.913461531242604,MAP2K1;DUSP6
KEGG_2021_Human,Long-term potentiation,2/67,0.481441220372952,0.9515627972731294,0,0,1.2496547294042075,0.913461531242604,MAP2K1;RAP1A
KEGG_2021_Human,Insulin resistance,3/108,0.4831373101022908,0.9515627972731294,0,0,1.1604303646144651,0.8441601511976026,PRKAB2;CD36;PPARGC1A
KEGG_2021_Human,Ribosome biogenesis in eukaryotes,3/108,0.4831373101022908,0.9515627972731294,0,0,1.1604303646144651,0.8441601511976026,NXF1;EFL1;GNL2
KEGG_2021_Human,Chemokine signaling pathway,5/192,0.4920096928595025,0.9515627972731294,0,0,1.085920999415809,0.7701969201540169,VAV3;ITK;MAP2K1;RAP1A;CCL4
KEGG_2021_Human,Transcriptional misregulation in cancer,5/192,0.4920096928595025,0.9515627972731294,0,0,1.085920999415809,0.7701969201540169,NR4A3;BCL11B;DUSP6;IGF1R;TGFBR2
KEGG_2021_Human,Renal cell carcinoma,2/69,0.4969412459154241,0.9515627972731294,0,0,1.212226965381859,0.8476902876869252,MAP2K1;RAP1A
KEGG_2021_Human,Phagosome,4/152,0.4987326793961995,0.9515627972731294,0,0,1.097569267380588,0.7635625190315148,TUBB8;TUBA1C;HLA-B;CD36
KEGG_2021_Human,Linoleic acid metabolism,1/29,0.5066187693610981,0.9515627972731294,0,0,1.4502232142857143,0.9861466989610632,PLA2G4C
KEGG_2021_Human,Oxytocin signaling pathway,4/154,0.5089594298950637,0.9515627972731294,0,0,1.0828232005590497,0.7313246816829013,MAP2K1;PRKAB2;PLA2G4C;MYLK
KEGG_2021_Human,Amyotrophic lateral sclerosis,9/364,0.5137041645050183,0.9515627972731294,0,0,1.0293387443303892,0.6856504991839845,TUBB8;TUBA1C;NXF1;GABARAPL1;PSMB3;VAPB;NUP153;COX7C;MCU
KEGG_2021_Human,Non-alcoholic fatty liver disease,4/155,0.5140375386148286,0.9515627972731294,0,0,1.075596651255779,0.715765454597713,PRKAB2;LEPR;ADIPOR2;COX7C
KEGG_2021_Human,Citrate cycle (TCA cycle),1/30,0.5185017899771778,0.9515627972731294,0,0,1.4001436781609196,0.9196308882462928,MDH2
KEGG_2021_Human,Glutamatergic synapse,3/114,0.519225008117927,0.9515627972731294,0,0,1.0973651475743529,0.719232813356358,TRPC1;PLA2G4C;CACNA1A
KEGG_2021_Human,Melanoma,2/72,0.5196293114089658,0.9515627972731294,0,0,1.1600954369221592,0.7594443945624547,MAP2K1;IGF1R
KEGG_2021_Human,p53 signaling pathway,2/73,0.5270388889006463,0.9515627972731294,0,0,1.1436972566085448,0.7325162941973462,ZMAT3;CCNG2
KEGG_2021_Human,RNA polymerase,1/31,0.53009918940522,0.9515627972731294,0,0,1.3534027777777775,0.8589927520763129,POLR2D
KEGG_2021_Human,PPAR signaling pathway,2/74,0.5343707939677034,0.9515627972731294,0,0,1.1277545813036418,0.7067246745894668,UBC;CD36
KEGG_2021_Human,Glioma,2/75,0.5416244702383427,0.9515627972731294,0,0,1.1122486916235308,0.6820112965663245,MAP2K1;IGF1R
KEGG_2021_Human,Shigellosis,6/246,0.5435111355071002,0.9515627972731294,0,0,1.014684210526316,0.6186581219313785,GABARAPL1;RRAGD;UBC;UBE2D1;RPS27A;NAIP
KEGG_2021_Human,Sphingolipid signaling pathway,3/119,0.5482304053240843,0.9515627972731294,0,0,1.0497944019621988,0.6309890376809895,ACER2;MAP2K1;DEGS2
KEGG_2021_Human,Chronic myeloid leukemia,2/76,0.5487994331710984,0.9515627972731294,0,0,1.0971618800428822,0.6583215238836743,MAP2K1;TGFBR2
KEGG_2021_Human,Pancreatic cancer,2/76,0.5487994331710984,0.9515627972731294,0,0,1.0971618800428822,0.6583215238836743,MAP2K1;TGFBR2
KEGG_2021_Human,Base excision repair,1/33,0.5524643657687863,0.9515627972731294,0,0,1.2686848958333334,0.7527949183493204,SMUG1
KEGG_2021_Human,SNARE interactions in vesicular transport,1/33,0.5524643657687863,0.9515627972731294,0,0,1.2686848958333334,0.7527949183493204,VAMP1
KEGG_2021_Human,Rap1 signaling pathway,5/210,0.5714973895759119,0.9515627972731294,0,0,0.9896495183439228,0.5537043169330678,VAV3;MAP2K1;RAP1A;SKAP1;IGF1R
KEGG_2021_Human,Hepatocellular carcinoma,4/168,0.5776718687712753,0.9515627972731294,0,0,0.9896712174668916,0.5430813606988992,MAP2K1;ARID1A;IGF1R;TGFBR2
KEGG_2021_Human,DNA replication,1/36,0.5840360040987447,0.9515627972731294,0,0,1.1597619047619048,0.6237114248838869,RNASEH2C
KEGG_2021_Human,Tyrosine metabolism,1/36,0.5840360040987447,0.9515627972731294,0,0,1.1597619047619048,0.6237114248838869,IL4I1
KEGG_2021_Human,Peroxisome,2/82,0.5901773327669151,0.9515627972731294,0,0,1.014561586638831,0.5350110170869902,GNPAT;NUDT12
KEGG_2021_Human,Thyroid cancer,1/37,0.5940579476341791,0.9515627972731294,0,0,1.127488425925926,0.5871716291134246,MAP2K1
KEGG_2021_Human,Oocyte meiosis,3/129,0.6030332205648816,0.9515627972731294,0,0,0.965979278740785,0.4885758894493409,MAP2K1;SPDYE3;IGF1R
KEGG_2021_Human,Purine metabolism,3/129,0.6030332205648816,0.9515627972731294,0,0,0.965979278740785,0.4885758894493409,DGUOK;PDE4A;ADPRM
KEGG_2021_Human,Allograft rejection,1/38,0.6038389184800805,0.9515627972731294,0,0,1.0969594594594594,0.5533587946508676,HLA-B
KEGG_2021_Human,Primary immunodeficiency,1/38,0.6038389184800805,0.9515627972731294,0,0,1.0969594594594594,0.5533587946508676,BTK
KEGG_2021_Human,Colorectal cancer,2/86,0.6161583979274734,0.9515627972731294,0,0,0.9660503032110548,0.4678110272950667,MAP2K1;TGFBR2
KEGG_2021_Human,Cardiac muscle contraction,2/87,0.6224530653064475,0.9515627972731294,0,0,0.9546358835809898,0.4525805104284236,TPM2;COX7C
KEGG_2021_Human,"Glycine, serine and threonine metabolism",1/40,0.622700932634459,0.9515627972731294,0,0,1.040598290598291,0.4929198797801851,GLYCTK
KEGG_2021_Human,Nicotine addiction,1/40,0.622700932634459,0.9515627972731294,0,0,1.040598290598291,0.4929198797801851,CACNA1A
KEGG_2021_Human,Bladder cancer,1/41,0.6317931285501529,0.9515627972731294,0,0,1.01453125,0.4658659188184778,MAP2K1
KEGG_2021_Human,Human cytomegalovirus infection,5/225,0.6324956250704664,0.9515627972731294,0,0,0.921457219251337,0.4221029431389814,MAP2K1;CCL4;HLA-B;ARHGEF1;B2M
KEGG_2021_Human,GABAergic synapse,2/89,0.6348026493778165,0.9515627972731294,0,0,0.9325942456746574,0.423809170502847,GABARAPL1;CACNA1A
KEGG_2021_Human,Axon guidance,4/182,0.6405877403666084,0.9515627972731294,0,0,0.9111723553105788,0.405808084473457,NRP1;TRPC1;PLXNA2;PLXNB1
KEGG_2021_Human,Graft-versus-host disease,1/42,0.6406666631503751,0.9515627972731294,0,0,0.9897357723577236,0.4406758774759304,HLA-B
KEGG_2021_Human,Tryptophan metabolism,1/42,0.6406666631503751,0.9515627972731294,0,0,0.9897357723577236,0.4406758774759304,IL4I1
KEGG_2021_Human,Insulin signaling pathway,3/137,0.643597870622838,0.9515627972731294,0,0,0.907934178479985,0.4001094982442629,MAP2K1;PRKAB2;PPARGC1A
KEGG_2021_Human,Prion disease,6/273,0.6446936553656272,0.9515627972731294,0,0,0.9107983441750443,0.399822282567963,TUBB8;EGR1;TUBA1C;PSMB3;COX7C;MCU
KEGG_2021_Human,Morphine addiction,2/91,0.646834067812893,0.9515627972731294,0,0,0.9115432431798456,0.3971279258034954,PDE4A;CACNA1A
KEGG_2021_Human,Fat digestion and absorption,1/43,0.6493267845402435,0.9515627972731294,0,0,0.9661210317460316,0.4171895809940065,CD36
KEGG_2021_Human,Type I diabetes mellitus,1/43,0.6493267845402435,0.9515627972731294,0,0,0.9661210317460316,0.4171895809940065,HLA-B
KEGG_2021_Human,Th1 and Th2 cell differentiation,2/92,0.6527311587420506,0.9515627972731294,0,0,0.90136859197402,0.3845147701892343,MAML2;STAT4
KEGG_2021_Human,Measles,3/139,0.6532700743980017,0.9515627972731294,0,0,0.894489908934285,0.3808421785464896,OAS3;MX2;MSN
KEGG_2021_Human,RNA transport,4/186,0.6573966870189966,0.9515627972731294,0,0,0.8909622871887023,0.3737298633368304,NXF1;NUP153;PABPC1L;EIF2B1
KEGG_2021_Human,Thermogenesis,5/232,0.6590791170329664,0.9515627972731294,0,0,0.8927183208084997,0.3721847087233448,PRKAB2;ARID1A;PPARGC1A;COX7C;MGLL
KEGG_2021_Human,TGF-beta signaling pathway,2/94,0.664289771655311,0.9515627972731294,0,0,0.8816828537714442,0.3606407521716123,ACVR2A;TGFBR2
KEGG_2021_Human,ABC transporters,1/45,0.6660271538007461,0.9515627972731294,0,0,0.9221117424242424,0.3747691153485156,ABCA9
KEGG_2021_Human,Basal transcription factors,1/45,0.6660271538007461,0.9515627972731294,0,0,0.9221117424242424,0.3747691153485156,TAF6L
KEGG_2021_Human,Proteasome,1/46,0.6740772811718592,0.9515627972731294,0,0,0.901574074074074,0.3555902941002887,PSMB3
KEGG_2021_Human,Type II diabetes mellitus,1/46,0.6740772811718592,0.9515627972731294,0,0,0.901574074074074,0.3555902941002887,CACNA1A
KEGG_2021_Human,Dilated cardiomyopathy,2/96,0.6755368536940775,0.9515627972731294,0,0,0.8628348065562119,0.3384448522294763,TPM2;EMD
KEGG_2021_Human,Prostate cancer,2/97,0.6810446303002643,0.9515627972731294,0,0,0.8537083836940995,0.3279328147078488,MAP2K1;IGF1R
KEGG_2021_Human,Nucleotide excision repair,1/47,0.6819337597386493,0.9515627972731294,0,0,0.881929347826087,0.3376226203030362,XPA
KEGG_2021_Human,Pyruvate metabolism,1/47,0.6819337597386493,0.9515627972731294,0,0,0.881929347826087,0.3376226203030362,MDH2
KEGG_2021_Human,Choline metabolism in cancer,2/98,0.6864758445501319,0.9515627972731294,0,0,0.8447720946416145,0.317789949049111,MAP2K1;PLA2G4C
KEGG_2021_Human,mRNA surveillance pathway,2/98,0.6864758445501319,0.9515627972731294,0,0,0.8447720946416145,0.317789949049111,NXF1;PABPC1L
KEGG_2021_Human,Human papillomavirus infection,7/331,0.6867412764539498,0.9515627972731294,0,0,0.8749088399229046,0.3287886919033748,MAP2K1;MAML2;MFNG;MX2;HLA-B;SCRIB;RFNG
KEGG_2021_Human,"Valine, leucine and isoleucine degradation",1/48,0.6896012384029129,0.9515627972731294,0,0,0.8631205673758865,0.3207716500371347,IL4I1
KEGG_2021_Human,Breast cancer,3/147,0.6900679991593667,0.9515627972731294,0,0,0.844447350069735,0.3132605266885078,MAP2K1;NCOA3;IGF1R
KEGG_2021_Human,Hematopoietic cell lineage,2/99,0.6918309848660915,0.9515627972731294,0,0,0.8360200589716549,0.3080011551831675,CD37;CD36
KEGG_2021_Human,Retrograde endocannabinoid signaling,3/148,0.694455331776096,0.9515627972731294,0,0,0.8385802914442361,0.3057693815102206,FAAH;CACNA1A;MGLL
KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,2/100,0.6971105604056224,0.9515627972731294,0,0,0.8274466362745516,0.298552061390083,EGR1;TGFBR2
KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,2/100,0.6971105604056224,0.9515627972731294,0,0,0.8274466362745516,0.298552061390083,CCL4;TNFSF10
KEGG_2021_Human,Spliceosome,3/150,0.7030891430246724,0.9515627972731294,0,0,0.8270856459738707,0.291358776794878,PPIE;DHX38;DHX16
KEGG_2021_Human,Arginine and proline metabolism,1/50,0.7043872370804651,0.9515627972731294,0,0,0.8278061224489796,0.2900856337670249,SAT1
KEGG_2021_Human,Malaria,1/50,0.7043872370804651,0.9515627972731294,0,0,0.8278061224489796,0.2900856337670249,CD36
KEGG_2021_Human,Pathways of neurodegeneration,10/475,0.7095086879630806,0.9515627972731294,0,0,0.8699860740131955,0.2985640282658633,TUBB8;TUBA1C;GABARAPL1;MAP2K1;PSMB3;VAPB;UBC;RPS27A;COX7C;MCU
KEGG_2021_Human,Cytokine-cytokine receptor interaction,6/295,0.7163236480887013,0.9515627972731294,0,0,0.8405026406847569,0.2804111736029181,CCL4;TNFSF10;LEPR;IFNLR1;ACVR2A;TGFBR2
KEGG_2021_Human,NF-kappa B signaling pathway,2/104,0.7174840575202699,0.9515627972731294,0,0,0.7948340087600803,0.2638885082608408,CCL4;BTK
KEGG_2021_Human,Toll-like receptor signaling pathway,2/104,0.7174840575202699,0.9515627972731294,0,0,0.7948340087600803,0.2638885082608408,MAP2K1;CCL4
KEGG_2021_Human,Epstein-Barr virus infection,4/202,0.7192329032658398,0.9515627972731294,0,0,0.8182876987908434,0.269683115397283,OAS3;HLA-B;BTK;B2M
KEGG_2021_Human,mTOR signaling pathway,3/154,0.7197966757109177,0.9515627972731294,0,0,0.8050098367923744,0.2646763680721805,MAP2K1;RRAGD;IGF1R
KEGG_2021_Human,Diabetic cardiomyopathy,4/203,0.7228091769400468,0.9515627972731294,0,0,0.8141335608861919,0.2642759147135513,CD36;COX7C;GAPDH;TGFBR2
KEGG_2021_Human,Autoimmune thyroid disease,1/53,0.7252586927733865,0.9515627972731294,0,0,0.7799278846153846,0.2505337933202571,HLA-B
KEGG_2021_Human,Hepatitis C,3/157,0.7318419225200515,0.9515627972731294,0,0,0.7892055643101669,0.2463826700680998,MAP2K1;OAS3;MX2
KEGG_2021_Human,Th17 cell differentiation,2/107,0.7319983507966838,0.9515627972731294,0,0,0.7720051694999502,0.2408478706869317,RORA;TGFBR2
KEGG_2021_Human,Regulation of lipolysis in adipocytes,1/55,0.7383493611863686,0.9515627972731294,0,0,0.7509645061728395,0.2277962044845694,MGLL
KEGG_2021_Human,Pyrimidine metabolism,1/56,0.744659376500956,0.9515627972731294,0,0,0.7372727272727273,0.2173689222565872,CMPK2
KEGG_2021_Human,Huntington disease,6/306,0.7481736862707917,0.9515627972731294,0,0,0.809221052631579,0.234771314613418,TUBB8;TUBA1C;PSMB3;POLR2D;PPARGC1A;COX7C
KEGG_2021_Human,Glutathione metabolism,1/57,0.7508175258705841,0.9515627972731294,0,0,0.7240699404761904,0.2075131097135937,GCLC
KEGG_2021_Human,Legionellosis,1/57,0.7508175258705841,0.9515627972731294,0,0,0.7240699404761904,0.2075131097135937,NAIP
KEGG_2021_Human,Hepatitis B,3/162,0.7510076007510206,0.9515627972731294,0,0,0.7641904160416831,0.2188179065471303,MAP2K1;STAT4;TGFBR2
KEGG_2021_Human,JAK-STAT signaling pathway,3/162,0.7510076007510206,0.9515627972731294,0,0,0.7641904160416831,0.2188179065471303,LEPR;STAT4;IFNLR1
KEGG_2021_Human,Endometrial cancer,1/58,0.7568274569188675,0.9515627972731294,0,0,0.7113304093567251,0.1981908655797691,MAP2K1
KEGG_2021_Human,Cholinergic synapse,2/113,0.7591308684682131,0.9515627972731294,0,0,0.7300494649137655,0.2011878303794943,MAP2K1;CACNA1A
KEGG_2021_Human,Herpes simplex virus 1 infection,10/498,0.7620568385504588,0.9515627972731294,0,0,0.8279819706936759,0.2249909644395197,NXF1;ZNF175;ZNF471;ZNF790;POU2F1;OAS3;HLA-B;ZNF426;EIF2B1;B2M
KEGG_2021_Human,cAMP signaling pathway,4/216,0.7662508824866751,0.9515627972731294,0,0,0.7636960563268858,0.2033307453103939,VAV3;MAP2K1;RAP1A;PDE4A
KEGG_2021_Human,Viral myocarditis,1/60,0.7684168195552886,0.9515627972731294,0,0,0.6871468926553672,0.1810102679131877,HLA-B
KEGG_2021_Human,Arachidonic acid metabolism,1/61,0.7740031174248274,0.9535399230130608,0,0,0.6756597222222223,0.173090087189266,PLA2G4C
KEGG_2021_Human,Neurotrophin signaling pathway,2/119,0.7838561774270463,0.955255439114289,0,0,0.6923969095159074,0.1686192273170752,MAP2K1;RAP1A
KEGG_2021_Human,Cytosolic DNA-sensing pathway,1/63,0.7847754992395688,0.955255439114289,0,0,0.6537970430107527,0.1584526759102793,CCL4
KEGG_2021_Human,Alzheimer disease,7/369,0.7873862824498533,0.955255439114289,0,0,0.7815173555260274,0.1868110342032986,TUBB8;TUBA1C;MAP2K1;PSMB3;COX7C;GAPDH;MCU
KEGG_2021_Human,Ras signaling pathway,4/232,0.8122094599897667,0.9655709161523068,0,0,0.7095148773401008,0.1475769776014789,MAP2K1;RAP1A;PLA2G4C;IGF1R
KEGG_2021_Human,Amphetamine addiction,1/69,0.8141140240744502,0.9655709161523068,0,0,0.5959252450980392,0.1225549133604946,SIRT1
KEGG_2021_Human,Renin secretion,1/69,0.8141140240744502,0.9655709161523068,0,0,0.5959252450980392,0.1225549133604946,CTSB
KEGG_2021_Human,Prolactin signaling pathway,1/70,0.8186000194723386,0.9655709161523068,0,0,0.5872584541062802,0.1175454707911925,MAP2K1
KEGG_2021_Human,RIG-I-like receptor signaling pathway,1/70,0.8186000194723386,0.9655709161523068,0,0,0.5872584541062802,0.1175454707911925,DHX58
KEGG_2021_Human,Relaxin signaling pathway,2/129,0.8201292718783192,0.9655709161523068,0,0,0.6375486988969803,0.1264216370196868,MAP2K1;TGFBR2
KEGG_2021_Human,Non-small cell lung cancer,1/72,0.8272504802834968,0.9691807097439008,0,0,0.5706572769953052,0.1082238695175737,MAP2K1
KEGG_2021_Human,Calcium signaling pathway,4/240,0.8322688788464832,0.9703037172893144,0,0,0.6851792630494261,0.1257987199406734,CACNA1A;MCOLN2;MCU;MYLK
KEGG_2021_Human,Gastric acid secretion,1/76,0.8433358436878844,0.9729346140307464,0,0,0.5401111111111111,0.0920295372064269,MYLK
KEGG_2021_Human,Estrogen signaling pathway,2/137,0.8451185343507132,0.9729346140307464,0,0,0.5995206062011907,0.100886358861049,MAP2K1;NCOA3
KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,1/77,0.8471179477850898,0.9729346140307464,0,0,0.5329769736842105,0.0884290560363611,EMD
KEGG_2021_Human,Synaptic vesicle cycle,1/78,0.8508089302611965,0.9729346140307464,0,0,0.5260281385281386,0.0849891561618549,CACNA1A
KEGG_2021_Human,Complement and coagulation cascades,1/85,0.8742719722863076,0.9759536511610571,0,0,0.4820188492063492,0.0647658700930307,PROCR
KEGG_2021_Human,ErbB signaling pathway,1/85,0.8742719722863076,0.9759536511610571,0,0,0.4820188492063492,0.0647658700930307,MAP2K1
KEGG_2021_Human,Phospholipase D signaling pathway,2/148,0.8743397303196032,0.9759536511610571,0,0,0.5540366631395316,0.0743995177087334,MAP2K1;PLA2G4C
KEGG_2021_Human,Gastric cancer,2/149,0.8767280784773221,0.9759536511610571,0,0,0.5502393024015452,0.0723885986297788,MAP2K1;TGFBR2
KEGG_2021_Human,Taste transduction,1/86,0.8773085938180631,0.9759536511610571,0,0,0.4763235294117647,0.0623490705490953,CACNA1A
KEGG_2021_Human,ECM-receptor interaction,1/88,0.883164015873093,0.9759536511610571,0,0,0.4653256704980842,0.0578140841602171,CD36
KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,1/89,0.8859862954467105,0.9759536511610571,0,0,0.4600142045454545,0.0556864658534559,MAP2K1
KEGG_2021_Human,Human immunodeficiency virus 1 infection,3/212,0.8876715583692125,0.9759536511610571,0,0,0.5798682709054874,0.0690933172642835,MAP2K1;HLA-B;B2M
KEGG_2021_Human,Cushing syndrome,2/155,0.8902004014774497,0.9759536511610571,0,0,0.528497550725231,0.0614688479648947,MAP2K1;RAP1A
KEGG_2021_Human,Hippo signaling pathway,2/163,0.9060446762538092,0.9769608324967726,0,0,0.5020293312931963,0.0495335586542984,SCRIB;TGFBR2
KEGG_2021_Human,Circadian entrainment,1/97,0.9062478355923654,0.9769608324967726,0,0,0.4215060763888889,0.0414940955401193,PER3
KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,1/98,0.9085135176253156,0.9769608324967726,0,0,0.417139175257732,0.0400226318276905,PLA2G4C
KEGG_2021_Human,cGMP-PKG signaling pathway,2/167,0.9131411475160848,0.9769608324967726,0,0,0.4897577022837983,0.0445017419538296,MAP2K1;MYLK
KEGG_2021_Human,Melanogenesis,1/101,0.9149879268494084,0.9769608324967726,0,0,0.4045625,0.0359431160112595,MAP2K1
KEGG_2021_Human,Chagas disease,1/102,0.9170427973328348,0.9769608324967726,0,0,0.400536303630363,0.0346868992186751,TGFBR2
KEGG_2021_Human,Protein processing in endoplasmic reticulum,2/171,0.9197330013044932,0.9769608324967726,0,0,0.4780669787896381,0.0400007566822661,UBXN1;UBE2D1
KEGG_2021_Human,Chemical carcinogenesis,3/239,0.9293306837490548,0.9827877584779828,0,0,0.5128093752216155,0.0375841308120289,MAP2K1;CACNA1A;KLF4
KEGG_2021_Human,TNF signaling pathway,1/112,0.935052906708976,0.9844830163147368,0,0,0.3642642642642643,0.024461134552586,MAP2K1
KEGG_2021_Human,"Growth hormone synthesis, secretion and action",1/119,0.9452830324909332,0.990888792830408,0,0,0.3425317796610169,0.0192745684543775,MAP2K1
KEGG_2021_Human,Dopaminergic synapse,1/132,0.9602065327291496,0.9952253924532468,0,0,0.3083333333333333,0.012520454481556,CACNA1A
KEGG_2021_Human,Oxidative phosphorylation,1/133,0.9611698701410346,0.9952253924532468,0,0,0.3059816919191919,0.0121181361642098,COX7C
KEGG_2021_Human,Fluid shear stress and atherosclerosis,1/139,0.9664802941934914,0.9952253924532468,0,0,0.2925875603864734,0.009975588358054,ACVR2A
KEGG_2021_Human,Cell adhesion molecules,1/148,0.9731179740343034,0.9952253924532468,0,0,0.2745464852607709,0.0074813797595051,HLA-B
KEGG_2021_Human,Pathways in cancer,7/531,0.9732845634199264,0.9952253924532468,0,0,0.5353375527426161,0.0144962876658592,MAP2K1;PLEKHG5;NCOA3;STAT4;ARHGEF1;IGF1R;TGFBR2
KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,1/150,0.9744047775483674,0.9952253924532468,0,0,0.2708333333333333,0.0070222963881538,TPM2
KEGG_2021_Human,Wnt signaling pathway,1/166,0.9827153588773682,0.9977914106063565,0,0,0.2443686868686868,0.0042607548686385,ZNRF3
KEGG_2021_Human,Tuberculosis,1/180,0.9877434431032002,0.9977914106063565,0,0,0.2250931098696461,0.0027759130414319,NFYC
KEGG_2021_Human,PI3K-Akt signaling pathway,3/354,0.991773218945806,0.9977914106063565,0,0,0.3427386188892465,0.0028312978446838,MAP2K1;CDC37;IGF1R
KEGG_2021_Human,MicroRNAs in cancer,2/310,0.9956394356483472,0.9977914106063565,0,0,0.2604316351706748,0.0011381121172621,MAP2K1;SIRT1
KEGG_2021_Human,Neuroactive ligand-receptor interaction,2/341,0.9977914106063565,0.9977914106063565,0,0,0.2362345348285821,0.0005223220981106649,CALCR;LEPR
